Valeant to buy Sprout Pharmaceuticals for $1 billion
Valeant Pharmaceuticals International Inc. plans to acquire Sprout Pharmaceuticals Inc., the maker of a just-approved drug for sexual desire disorder in women, for about $1 billion in cash.
Supplier News
NBTY tabs former Coca-Cola exec for new public affairs post
NBTY Inc. has hired former Coca-Cola executive Sonya Soutus to the newly created position of senior vice president of public affairs and communications.
PharmaSmart partners with Chain Drug Review
PharmaSmart International Inc. and Chain Drug Review have teamed up to help pharmacists help their patients lower their blood pressure.
Kirby Lester powers award-winning pharmacies
The majority of award-winning community pharmacies use Kirby Lester prescription dispensing technology, according to an analysis by the pharmacy automation provider. Kirby Lester said Wednesday that of the U.S.
FDA OKs first drug for women’s sexual desire disorder
Sprout Pharmaceuticals Inc. has gained Food and Drug Administration clearance to market Addyi, which the company calls the first FDA-approved medication for hypoactive sexual desire disorder (HSDD) in women. Sprout said late Tuesday that Addyi (flibanserin, 100 mg) is slated to be released by Oct.
Aurobindo cleared to market generic Zyrtec tablets
Aurobindo Pharma Ltd. has received approval from the Food and Drug Administration for cetirizine hydrochloride tablets, 5 mg and 10 mg, an over-the-counter allergy medication.
First Abilify oral solution generics released by Lannett, Amneal
Lannett Co. and Amneal Pharmaceuticals LLC have launched the first generic versions of Abilify oral solution (aripiprazole 1 mg/ml), Otsuka Pharmaceutical’s antidepressant drug.
Hello children’s toothpaste earns ADA seal
Hello Products LLC’s collection of toothpastes for children has received the American Dental Association (ADA) Seal of Acceptance.
Eli Lilly ships Humalog U-200 KwikPen
Eli Lilly & Co. has rolled out the Humalog 200 units/ml KwikPen to U.S. pharmacies, calling the medication the nation’s first and only concentrated mealtime insulin analog.
NBTY acquires Dr. Organic skin care line
NBTY Inc., a supplier of vitamins, nutritional supplements and sports nutrition, has agreed to acquire Dr. Organic, a naturally inspired skin care line in the U.K. The deal is subject to customary closing conditions, and is expected to close later this year. The Dr.
Jergens ads promote skin care “breakthrough”
Kao USA Inc. has announced a campaign promoting an addition to the Jergens Skincare brand that features actress Leslie Mann in ads that aim to get women thinking beyond their face and hair to “their oft-neglected beauty assets: the skin on their bodies.
PepsiCo introduces aspartame-free Diet Pepsi
PepsiCo has unveiled aspartame-free Diet Pepsi as a new option for cola fans. “Diet cola drinkers in the U.S. told us they wanted aspartame-free Diet Pepsi, and we’re delivering,” said Seth Kaufman, senior vice president Pepsi and Flavors portfolio, PepsiCo North America Beverages.
Galderma launches two Benzac acne products
Benzac Skin Refining Mask and Benzac Acne Eliminating Cleanser. “The addition of Benzac Skin Refining Mask and Benzac Acne Eliminating Cleanser allows teens to customize a highly effective skin care regimen that quickly clears up mild-to-moderate
Jouviance skin care to make U.S. debut at CVS
Canadian brand Jouviance plans to enter the U.S. market with the launch of its dermatological skin care line exclusively at CVS/pharmacy stores.
Upsher-Smith gains approval for Namenda generic
Upsher-Smith Laboratories Inc. has received approval from the Food and Drug Administration of an Abbreviated New Drug Application (ANDA) for memantine hydrochloride tablets, a treatment for Alzheimer’s disease, in strengths of 5 mg and 10 mg.
FLAVORx rolls out iPhone app
FLAVORx aims to help improve adherence to pediatric medications with the launch of its first mobile application for iPhone.